Results 171 to 180 of about 61,607 (214)

Clinical tolerance in allogeneic hematopoietic stem cell transplantation

Immunological Reviews, 2011
Summary:  Allogeneic hematopoietic stem cell transplantation (HSCT) has been a curative therapeutic option for a wide range of immune hematologic malignant and non‐malignant disorders including genetic diseases and inborn errors. Once in the host, allogeneic transplanted cells have not only to ensure myeloid repopulation and immunological ...
RONCAROLO , MARIA GRAZIA, Gregori S, Lucarelli B, CICERI, FABIO, Bacchetta R.   +4 more
openaire   +3 more sources

Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes

Clinical Lymphoma Myeloma and Leukemia, 2013
Allogeneic stem cell transplantation (SCT) is the only treatment with curative potential for myelodysplastic syndrome (MDS). The availability of SCT has been expanded with the introduction of reduced intensity conditioning for older patients and the use of alternative donors.
Betul, Oran, Uday, Popat, Borje, Andersson, Richard, Champlin   +3 more
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

Annals of Neurology, 2014
Neuromyelitis optica is a rare neurological autoimmune disorder characterized by a poor prognosis. Immunosuppression can halt disease progression, but some patients are refractory to multiple treatments, experiencing frequent relapses with accumulating disability.
Greco R, BONDANZA , ATTILIO, Vago L, Moiola L, Rossi P, Furlan R, MARTINO , GIANVITO, Radaelli M, Martinelli V, Carbone MR, Lupo Stanghellini MT, Assanelli A, Bernardi M, Corti C, Peccatori J, BONINI , MARIA CHIARA, Vezzulli P, FALINI , ANDREA, CICERI , FABIO, COMI , GIANCARLO   +19 more
openaire   +3 more sources

Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita

Current Opinion in Hematology, 2016
Purpose of reviewDyskeratosis congenita is an inherited bone marrow failure syndrome caused by defects in telomere maintenance. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for bone marrow failure because of dyskeratosis congenita.
Shaimaa, Elmahadi, Hideki, Muramatsu, Seiji, Kojima   +2 more
openaire   +2 more sources

Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation

Experimental Hematology, 2003
The toxicities associated with conventional myeloablative therapy and allogeneic hematopoietic stem cell transplantation (SCT) limit the use of this potentially curative approach to relatively healthy young patients. The risk of treatment-related morbidity and mortality with conventional allogeneic SCT ranges from 10% to 50%, depending on the age of ...
Imad A, Tabbara, Richard M, Ingram
openaire   +2 more sources

Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation

Oncology Nursing Forum, 2015
A 32-year-old woman named A.C. was diagnosed five years ago with stage IIIB nodular sclerosing Hodgkin lymphoma (HL). Following initial chemotherapy, she had refractory disease as evidenced by hypermetabolic activity on positron-emission tomography (PET) scan. A.C.
Tracy, Robinson, Erin, Streu
openaire   +2 more sources

Development of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

2002
The field of BMT has entered a new phase based on insights into basic molecular and cellular biology. The mechanism of cure mediated by allogeneic HSCT is now believed to be at least partially mediated by cellular attack against tumor-associated antigens.
Januario E, Castro, Edward D, Ball
openaire   +2 more sources

Outcome Predictors of Allogeneic Hematopoietic Stem Cell Transplant

The American Journal of the Medical Sciences, 2013
Acute kidney injury (AKI) is a significant complication after hematopoietic stem cell transplantation (HSCT) and frequently limits treatment success. Patients suffering complications with AKI often have high mortality. This investigation analyzed the outcomes of patients receiving allogeneic HSCT and identified the association between prognosis and ...
Wen-Chi, Yang, Yih-Ting, Chen, Wei-Wen, Chang, Chih-Hsiang, Chang, Pei-Chun, Fan, Shen-Yang, Lee, Kuo-Chin, Kao, Ya-Chung, Tian, Cheng-Chieh, Hung, Ji-Tseng, Fang, Chih-Wei, Yang, Yung-Chang, Chen, Po-Nan, Wang   +12 more
openaire   +2 more sources

Transfusion policy in allogeneic hematopoietic stem cell transplantation

Transfusion and Apheresis Science, 2018
The incompatibility of ABO blood group between the recipient and the donor is not a barrier to perform allogeneic hematopoietic stem cell transplantation (Allo-HSCT). However, ABO incompatibility may lead to many complications during and after stem cell transplantation at the early or late period.
openaire   +2 more sources

Allogeneic Transplantation of Hematopoietic Stem Cells

2012
Molecular and cytometric studies of human hematopoietic stem cells and its microenvironment have greatly contributed to a better understanding of their biology, including regulation of their function and mutual interaction. This has resulted in the improvements of the procedure of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for ...
openaire   +1 more source